Cargando…
Impact of heart rate variability, a marker for cardiac health, on lupus disease activity
BACKGROUND: Decreased heart rate variability (HRV) is associated with adverse outcomes in cardiovascular diseases and has been observed in patients with systemic lupus erythematosus (SLE). We examined the relationship of HRV with SLE disease activity and selected cytokine pathways. METHODS: Fifty-th...
Autores principales: | Thanou, Aikaterini, Stavrakis, Stavros, Dyer, John W., Munroe, Melissa E., James, Judith A., Merrill, Joan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010705/ https://www.ncbi.nlm.nih.gov/pubmed/27590046 http://dx.doi.org/10.1186/s13075-016-1087-x |
Ejemplares similares
-
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
por: Thanou, Aikaterini, et al.
Publicado: (2019) -
Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?
por: Thanou, A, et al.
Publicado: (2012) -
Which outcome measures in SLE clinical trials best reflect medical judgment?
por: Thanou, Aikaterini, et al.
Publicado: (2014) -
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers
por: Arriens, Cristina, et al.
Publicado: (2020) -
An update on belimumab for the treatment of lupus
por: Thanou-Stavraki, Aikaterini, et al.
Publicado: (2011)